Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
Establishing a High-Throughput Kinetic Image Cytometry Assay to Assess Titin Variant-Induced Arrhythmogenic Properties of Human Induced-Pluripotent Stem Cell Cardiomyocytes
FY 2024-25
Summary
The heart relies on a protein called titin, produced by the TTN gene, to maintain its structure and function. Some individuals have genetic changes in TTN, known as truncating variants (TTNtv), which can lead to life-threatening heart conditions, including arrhythmias (irregular heartbeats) and dilated cardiomyopathy (DCM). Although TTNtv affects 1% of the population, not everyone with this mutation develops severe heart problems, making it difficult to predict who is at risk. TTNtv carriers are also more sensitive to certain medications, increasing their chances of experiencing harmful side effects called cardiotoxic adverse drug reactions (ADRs). Unfortunately, there are no targeted therapies for TTNtv carriers, and current drug safety tests dont account for genetic differences like TTNtv. To address this, the project will use heart cells created from stem cells from patients with TTNtv. These stem cells, reprogrammed from a patient blood, are turned into heart cells in the lab. Corrected versions of these cells (the harmful mutation is fixed) will also be used for comparison. The cells will be grown in dishes and tested with a specialized imaging device that measures their electrical activity and calcium handling-both essential for heart function. This system will study how different drugs affect the cells in real time and can detect tiny changes in their behaviour. By integrating robotics, thousands of drugs can be screened quickly and accurately. This work will improve drug safety by identifying risks specific to TTNtv carriers and pave the way for personalized treatments tailored to individual genetics. Given the prevalence of TTNtv, these findings could protect millions of people from preventable drug-induced heart problems and advance personalized medicine.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530030
Name
Donaldson-Barrio Georgia
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Establishing a High-Throughput Kinetic Image Cytometry Assay to Assess Titin Variant-Induced Arrhythmogenic Properties of Human Induced-Pluripotent Stem Cell Cardiomyocytes
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Drug Reactions (Adrs); Cardiac Arrhythmias; Cardiomyocytes; Cardiotoxicity; Dilated Cardiomyopathy (Dcm); High-Throughput Screening; Human Induced-Pluripotent Stem Cells; Kinetic Image Cytometry; Personalized Medicine; Titin Truncating Mutations (Ttntv)
Abstract
The heart relies on a protein called titin, produced by the TTN gene, to maintain its structure and function. Some individuals have genetic changes in TTN, known as truncating variants (TTNtv), which can lead to life-threatening heart conditions, including arrhythmias (irregular heartbeats) and dilated cardiomyopathy (DCM). Although TTNtv affects 1% of the population, not everyone with this mutation develops severe heart problems, making it difficult to predict who is at risk. TTNtv carriers are also more sensitive to certain medications, increasing their chances of experiencing harmful side effects called cardiotoxic adverse drug reactions (ADRs). Unfortunately, there are no targeted therapies for TTNtv carriers, and current drug safety tests dont account for genetic differences like TTNtv. To address this, the project will use heart cells created from stem cells from patients with TTNtv. These stem cells, reprogrammed from a patient blood, are turned into heart cells in the lab. Corrected versions of these cells (the harmful mutation is fixed) will also be used for comparison. The cells will be grown in dishes and tested with a specialized imaging device that measures their electrical activity and calcium handling-both essential for heart function. This system will study how different drugs affect the cells in real time and can detect tiny changes in their behaviour. By integrating robotics, thousands of drugs can be screened quickly and accurately. This work will improve drug safety by identifying risks specific to TTNtv carriers and pave the way for personalized treatments tailored to individual genetics. Given the prevalence of TTNtv, these findings could protect millions of people from preventable drug-induced heart problems and advance personalized medicine.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Donaldson-Barrio, Georgia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~